Esches, France

Patrick Ladam


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Patrick Ladam

Introduction

Patrick Ladam is an accomplished inventor based in Esches, France. He has made significant contributions to the field of medical science, particularly through his innovative work on peptidomimetics. His research focuses on developing novel compounds that can have a profound impact on various health conditions.

Latest Patents

Ladam holds a patent for "Peptidomimetics with antiangiogenic activity." This patent discloses novel peptidomimetics that exhibit antiangiogenic properties and outlines their potential uses in treating neoplasms and chronic inflammation. The applications of his invention extend to conditions such as rheumatoid arthritis, colitis, eczema, diabetes, age-related macular degeneration (ARMD), nephropathy, and neuropathy. His work emphasizes the administration of these compounds through intravenous infusions, injections, or implants that release the active ingredient. He has 1 patent to his name.

Career Highlights

Ladam's career is marked by his dedication to advancing medical treatments through innovative research. His work has not only contributed to scientific knowledge but also holds promise for improving patient outcomes in various diseases.

Collaborations

Throughout his career, Patrick Ladam has collaborated with notable colleagues, including Aleksandra Misicka-Kęsik and Dagmara Tymecka. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

In summary, Patrick Ladam is a notable inventor whose work on peptidomimetics has the potential to transform treatment options for several chronic conditions. His contributions to medical science are commendable and reflect his commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…